Sana Biotechnology Inc (SANA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -266,759 | -283,255 | -269,476 | -355,928 | -285,305 |
| Depreciation Amortization | 17,391 | 24,557 | 15,625 | 11,070 | 5,921 |
| Accounts payable and accrued liabilities | 1,377 | 1,027 | 1,058 | -266 | 1,982 |
| Other Working Capital | -1,185 | 18,611 | 7,542 | 9,801 | 6,156 |
| Other Operating Activity | 26,023 | -14,522 | -44,799 | 84,269 | 133,264 |
| Operating Cash Flow | $-223,153 | $-253,582 | $-290,050 | $-251,054 | $-137,982 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -33,430 | -20,032 | -20,876 | -29,862 | -23,872 |
| Purchase Of Investment | -226,064 | -157,744 | -78,688 | -491,387 | -387,432 |
| Sale Of Investment | 276,947 | 349,788 | 310,126 | 280,025 | 158,741 |
| Other Investing Activity | 0 | 0 | 0 | -4,574 | 0 |
| Investing Cash Flow | $17,453 | $172,012 | $210,562 | $-245,798 | $-252,563 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 7,744 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 192,005 | 31,646 | 4,913 | 631,751 | 149 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 435,538 |
| Financing Cash Flow | $199,749 | $31,646 | $4,913 | $631,751 | $435,687 |
| Beginning Cash Position | 137,349 | 187,273 | 261,848 | 126,949 | 81,807 |
| End Cash Position | 131,398 | 137,349 | 187,273 | 261,848 | 126,949 |
| Net Cash Flow | $-5,951 | $-49,924 | $-74,575 | $134,899 | $45,142 |
| Free Cash Flow | |||||
| Operating Cash Flow | -223,153 | -253,582 | -290,050 | -251,054 | -137,982 |
| Capital Expenditure | -33,430 | -20,032 | -20,876 | -29,862 | -23,872 |
| Free Cash Flow | -256,583 | -273,614 | -310,926 | -280,916 | -161,854 |